-
-
The conventional wisdom in research circles is that IRBs are the main drag on the process, slowing down the progress of a clinical trial with an unnecessarily complicated review system.
-
A major pharmaceutical company is leading the way to making accreditation as ubiquitous among IRBs as it is among health care organizations.
-
Electronic IRB submission technology can be of great use to even small research institutions, once it's integrated with existing technology.
-
IRBs often seek new members who are experienced scientists, professors, and medical doctors. But they might be missing an opportunity to educate and engage young scientists by overlooking that pool of potential ethics board members.
-
As the use of chemotherapeutic agents and hazardous drugs becomes more commonplace, hospitals are placing a new focus on identifying potential reproductive hazards.
-
A manufacturer of needle removal and disposal devices is seeking to expand the company's marketing niche by appealing to hospitals that are seeking to cut costs.
-
-
The air is clearing in the nation's operating rooms, as The Joint Commission places a greater emphasis on evacuating smoke from electrocautery procedures.
-
Health care workers may be among those who benefit from the recent spending boost in Washington, DC. The 2009 Omnibus Appropria-tions Bill includes language that directs $3 million to the National Institute for Occupational Safety and Health (NIOSH) to fund research into the modes of transmission of influenza and respirators and other personal protective equipment (PPE) that protect health care workers.
